Inspire Medical ( ($INSP) ) has released its Q4 earnings. Here is a breakdown of the information Inspire Medical presented to its investors.

A hypoglossal nerve stimulator implant is a device surgically placed inside the body to treat obstructive sleep apnea. Inspire is currently the only brand approved by the Food and Drug Administration ...

If additional information is needed, such as diagnostic or billing ... 2021 Mar;21(5):1784. doi:10.3390/s21051784 Inspire Sleep Apnea Innovation. Frequently asked questions. National Heart, Lung, and ...

Nearly 1 in 5 women and more than one-third of men in the United States have sleep apnea. This common sleep ... cases a surgical device called Inspire (hypoglossal nerve surgery) can be implanted.

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...

We’re proud to offer Inspire upper airway stimulation therapy, a new treatment option for obstructive sleep apnea. Long Island Jewish Medical Center and Glen Cove Hospital are the only hospitals on ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

Obstructive sleep apnea is caused by the collapse of the upper airway during sleep. The muscles supporting soft tissues in the throat relax, narrowing or closing the airway and temporarily ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...